What 7 Analyst Ratings Have To Say About Confluent
Confluent (NASDAQ:CFLT) has observed the following analyst ratings within the last quarter:
Wells Fargo Maintains Overweight on Confluent, Lowers Price Target to $55
Wells Fargo analyst Michael Turrin maintains Confluent (NASDAQ:CFLT) with a Overweight and lowers the price target from $75 to $55.
78 Biggest Movers From Friday
Gainers
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab.
What 8 Analyst Ratings Have To Say About Confluent
Within the last quarter, Confluent (NASDAQ:CFLT) has observed the following analyst ratings:
41 Stocks Moving In Friday’s Mid-Day Session
Gainers
Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday.
Deutsche Bank Maintains Hold on Confluent, Lowers Price Target to $63
Deutsche Bank analyst Patrick Colville maintains Confluent (NASDAQ:CFLT) with a Hold and lowers the price target from $84 to $63.
Analyst Ratings For Confluent
Analysts have provided the following ratings for Confluent (NASDAQ:CFLT) within the last quarter: